The accuracy of estimations of liver volume
Jessica Walter, Susanne Isabel Orth, Dieter C. Broering – 1 March 2010
Late reuse of liver allografts from brain‐dead graft recipients: The Munich experience and a review of the literature
Markus Rentsch, Jens Meyer, Joachim Andrassy, Carl‐Ludwig Fischer‐Fröhlich, Christan Rust, Susanna Mueller, Martin Angele, Florian Löhe, Karl‐Walter Jauch, Christian Graeb – 1 March 2010 – The increasing donor organ shortage requires the consideration of any possible organ donor in order to meet the current demand. However, the growing number of long‐term survivors of liver transplantation may create a situation in which former organ recipients may experience brain death with a functioning graft and therefore become organ donors themselves.
Contrast‐enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm
Rong‐Qin Zheng, Ren Mao, Jie Ren, Er‐Jiao Xu, Mei Liao, Ping Wang, Min‐Qiang Lu, Yang Yang, Chang‐Jie Cai, Gui‐Hua Chen – 1 March 2010 – Hepatic artery stenosis (HAS) is a common complication in liver transplant patients. Conventional angiography remains the gold standard for diagnosis. Recently, contrast‐enhanced ultrasound (CEUS) has begun providing real‐time angiographic‐like images of vessels and allowing the accurate diagnosis of arterial diseases such as hepatic artery thrombosis.
Reply
Salvador Benlloch, Marina Berenguer, Joaquin Primo – 1 March 2010
Institute of Medicine recommendations for the prevention and control of hepatitis B and C
Abigail E. Mitchell, Heather M. Colvin, R. Palmer Beasley – 22 February 2010 – Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%‐2% of the U.S. population has chronic HBV or HCV infections, and each year about 15,000 people die from liver cancer or liver disease related to these preventable infections.
Successful curative extracorporeal hepatic resection for far‐advanced hepatocellular carcinoma in an adolescent patient
Keishi Sugimachi, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Yo‐Ichi Yamashita, Kenji Umeda, Kazutoyo Morita, Yoshihiko Maehara – 19 February 2010
Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients
Timothy J. S. Cross, Andrew K. Burroughs, Phillip M. Harrison – 19 February 2010
Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation
Ali Raza, George Dikdan, Kunj K. Desai, Asif Shareef, Helen Fernandes, Virginie Aris, Andrew N. de la Torre, Dorian Wilson, Adrian Fisher, Patricia Soteropoulos, Baburao Koneru – 19 February 2010 – The benefits of ischemic preconditioning (IPC) in reducing ischemia/reperfusion injury (IRI) remain indistinct in human liver transplantation (LT). To further understand mechanistic aspects of IPC, we performed microarray analyses as a nested substudy in a randomized trial of 10‐minute IPC in 101 deceased donor LTs.
International Liver Transplantation Society 2009 presidential address: The internationalization of liver transplantation
Ronald W. Busuttil – 12 February 2010
Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma
Woo Young Shin, Kyung‐Suk Suh, Hae Won Lee, Joohyun Kim, Taehoon Kim, Nam‐Joon Yi, Kuhn Uk Lee – 12 February 2010 – Liver transplantation is regarded as an effective treatment for early hepatocellular carcinoma (HCC). However, some patients experience recurrence and subsequently rapid progression of the disease. We investigated prognostic factors affecting survival after recurrence in patients who underwent adult living donor liver transplantation (LDLT) for HCC. From October 1992 to December 2005, 138 adult patients underwent LDLT for HCC.